Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Binding of the angiogenic/senescence inducer CCN1/CYR61 to integrin α6β1 drives endocrine resistance in breast cancer cells

Aging(2022)10.18632/aging.203882Source: DataRank Database

Binding of the angiogenic/senescence inducer CCN1/CYR61 to integrin α6β1 drives endocrine resistance in breast cancer cells is a research paper published in Aging (2022). On theSindex it has a DataRank of 0. It has been cited 11 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access11 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.86)OA: hybridTopics (60)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Lin Yang ORCID,Travis Vander Steen,Luciano Vellón,Elisabet Cuyàs ORCID,Sara Verdura ORCID

Live enrichment

PubMed:35148282 PMC:PMC8876916 OpenAlex:https://openalex.org/W4211200016

NCI NIH HHS

Grant: R01 CA116623

NCI NIH HHS

Grant: R01 CA118975

National Institutes of Health

Grant: 5R01CA118975-05

Cyr61-induced breast cancer: Clinical relevance and therapeutic development

National Institutes of Health

Grant: 5R01CA116623-03

Fatty Acid Synthase:Molecular Target for Breast Cancer Therapy &Chemoprevention

FWCI

0.86

Citation Percentile

0.7%

Citation Trend

2023

2024

2025

hybridLicense: cc-by

journalhttps://www.aging-us.com/article/203882/pdf

publisherhttps://www.aging-us.com/article/203882/pdf

publisherhttps://www.aging-us.com/lookup/doi/10.18632/aging.203882

journalhttps://doi.org/10.18632/aging.203882

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35148282

Fields of Study

Connective Tissue Growth Factor Research0301 basic medicine03 medical and health sciences0303 health sciencesBreast NeoplasmsCysteine-Rich Protein 61Estrogen Receptor alphaFemaleHumansIntegrin alpha6beta1IntegrinsTamoxifen

MeSH Terms

Breast NeoplasmsFemaleHumansTamoxifenIntegrinsIntegrin alpha6beta1Estrogen Receptor alphaCysteine-Rich Protein 61

Keywords

CYR61BiologyCell biologyEstrogen receptorMatricellular proteinCancer researchReceptorCTGFGrowth factorBiochemistryCancerExtracellular matrixBreast cancerGeneticsIntegrinsTamoxifenMatricellular ProteinsCCN FamilyBreast NeoplasmsQuimioreceptorsEstrògens -- ReceptorsEstrogen -- Receptorshttps://purl.org/becyt/ford/1.6Biochemistry, Genetics and Molecular BiologyHumansRole of CCN Proteins in Signaling Pathwayshttps://purl.org/becyt/ford/1Molecular BiologyIntegrin alpha6beta1ChemoreceptorsBreast -- Cancer -- TreatmentEstrogen Receptor alphaLife SciencesMama -- Càncer -- TractamentFOS: Biological sciencesBreast -- Cancer -- Endocrine aspectsFemaleMama -- Càncer -- Aspectes endocrinsResearch PaperCysteine-Rich Protein 61

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being